Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
Does This Adult Patient Have Septic Arthritis?
2007
The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies
2002 Standout
Estimating kinetic parameters from dynamic contrast-enhanced t1-weighted MRI of a diffusable tracer: Standardized quantities and symbols
1999 Standout
Adrenal tissue characterization with 0.5‐T MR imaging: Value of T2*‐weighted images
1993
Imaging of incidentally discovered adrenal masses
1998
Work-up of the diabetic foot
2002
Magnetic resonance of focal liver lesions in hepatic cirrhosis and chronic hepatitis
2002
Prosthetic-Joint Infections
2004 Standout
Phaeochromocytoma
2005 Standout
MRI as an Alternative to CT-Guided Biopsy of Adrenal Masses in Patients With Lung Cancer
1998
Adoptive transfer of regulatory NKT lymphocytes ameliorates non‐alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping
2006
Inflammation and insulin resistance
2006 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
MR imaging of the diabetic foot
2004
Clinical and Surgical Staging of Non-Small Cell Lung Cancer
2000
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
MR Imaging of the Diabetic Foot: Diagnostic Challenges
2005
An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases.
1995
MR imaging contrast agents — what's in a name?
1997
Hepatocellular Carcinoma in the Cirrhotic Liver: Double-Contrast MR Imaging for Diagnosis
2000
Complex Regional Pain Syndrome Type I: Use of the International Association for the Study of Pain Diagnostic Criteria Defined in 1994
2002
Septic arthritis
2011
Diabetic Foot Disorders: A Clinical Practice Guideline (2006 Revision)
2006 Standout
Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures.
1995
Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases
1996
Incidentally Discovered Adrenal Masses*
1995
Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT.
1998
Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma
2004
Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours?
2008
Chemical Shift MR Imaging of Hyperattenuating (>10 HU) Adrenal Masses: Does It Still Have a Role?
2004
Validation of proposed diagnostic criteria (the “Budapest Criteria”) for Complex Regional Pain Syndrome
2010 Standout
Diagnosis of adrenal adenoma: Value of central spot of high-intensity hyperintense rim sign and homogeneous isointensity to liver on gadolinium-enhanced fat-suppressed spin-echo MR images
1999
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Low-Density Pheochromocytoma on CT:A Mimicker of Adrenal Adenoma
2003
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
CT guided percutaneous adrenal biopsy for lesions with equivocal findings in chemical shift MR imaging.
2008
Adrenal adenomas: Characteristic postgadolinium capillary blush on dynamic MR imaging
2001
Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer
1994
Acute Septic Arthritis
2002
Adrenal phaeochromocytoma: correlation of MRI appearances with histology and function
2008
Delivery of diagnostic agents for magnetic resonance imaging
1999
18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
2001
Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography
2004
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
Adrenal Mass Evaluation in Patients with Lung Carcinoma
2000
The Incidental Adrenal Mass on CT: Prevalence of Adrenal Disease in 1,049 Consecutive Adrenal Masses in Patients with No Known Malignancy
2008
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
THE INCIDENTAL ADRENAL MASS
1996
THE CASE FOR LAPAROSCOPIC ADRENALECTOMY
2001
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
2004
Imaging of Adrenal Incidentalomas: Current Status
2002
Magnetic nanoparticle design for medical diagnosis and therapy
2004 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Use of [18F]Fluorodeoxyglucose Positron Emission Tomography in Evaluating Locally Recurrent and Metastatic Adrenocortical Carcinoma
2006
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Works of T Matteuccí being referenced
Early hepatocellular carcinoma that develops within macroregenerative nodules: growth rate depicted at serial MR imaging.
1995
Synovial effusion in reflex sympathetic dystrophy: an additional sign for diagnosis and staging
1998
The septic versus nonseptic inflamed joint: MRI characteristics
1999
Adrenal gland enhancement at MR imaging with Mn-DPDP.
1995
Benign adrenocortical masses: diagnosis with chemical shift MR imaging.
1992
Clinical and US findings in prostate cancer: patients with normal prostate-specific antigen levels.
1993